Abramson Cancer Center

Clinical Trials

Brain Tumor Trials

• A Phase I Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma


• Detection of Vascular and Neuronal Changes Following Proton and/or Photon Radiotherapy in Patients Receiving Skull Base and/or Brain Radiation


• Effect of Pasireotide LAR on Gonadotroph Adenomas: A Pilot Study


• Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas


• Feasibility and Phase II Study Using Proton Radiation For WHO Grade I-III Meningiomas and Hemangiopericytomas


• Multimodality Statistical Model of Early Response of High Grade Glioma to Radiation Therapy


• Multimodality Statistical Model of Early Response of High Grade Glioma to Radiation Therapy


• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer


• PHASE II, Single-arm, Open-label Investigation of HSPPC-96 Vaccine With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme


• Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients With One to Three Cerebral Metastases


• Proton Radiation for Low Grade Gliomas


• Proton Radiation for Low Grade Gliomas